The difference in immune responses against GBM in the mouse model related to the therapeutic effects between the cocktail of multi-epitope peptides vaccine and the long multi-epitope peptide in combination with lenalidomide and anti-PD1 vaccine was investigated in this study. Here, PDCD1 is linked to glioblastoma.